Previous close | 0.0200 |
Open | 0.0100 |
Bid | 0.0000 |
Ask | 0.0500 |
Strike | 2.00 |
Expiry date | 2024-05-17 |
Day's range | 0.0100 - 0.0500 |
Contract range | N/A |
Volume | |
Open interest | 1.75k |
Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John Butler, Chief Executive Officer, will participate in a fireside chat at the 2nd Annual HCW Bioconnect Investor Conference on Monday, May 20th, 2024 at 3:00 p.m. ET.
The analysts covering Akebia Therapeutics, Inc. ( NASDAQ:AKBA ) delivered a dose of negativity to shareholders today...
Insights into Akebia Therapeutics' Performance and Strategic Developments